Christopher Chambliss in Daytona Beach, Florida

Home Florida Daytona Beach

Christopher Chambliss has Nurse Practitioner as his primary medical specialty. Their primary office is: 1667 N Clyde Morris Blvd in Daytona Beach, Florida.

They're a part of the: Lakeside Endocrine Associates Inc medical group which has around 3 members. You can call their office at 386-274-1414 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 2020 (around 4 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Christopher Dylan Chambliss Office Phone and Directions

Christopher Chambliss
Lakeside Endocrine Associates Inc
1667 N Clyde Morris Blvd
Daytona Beach, Florida 32117
386-274-1414

Patient Ratings
Please rate your experience with Christopher Chambliss below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 386-274-1414

Enter a starting address:

Healthcare Info for Christopher Chambliss

Medical School: Sorry, his university is not listed
Graduation Year: 2020
The Primary Medical Specialty for Christopher Chambliss is listed as: Nurse Practitioner
Approximate Years of Experience: 4
PAC (PECOS ID)#: 0547676629
NPI #: 1801489497
NPI Created On: 02/16/2021
NPI Last Updated Listed as: 03/09/2022
Primary Taxonomy Code: 363LF0000X
License Number:
APRN1101662
Listed Gender: Male

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $100

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest:

Third party is a Charity:: No

Record ID:: 763513430

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: DIABETES

Name of Drug #1: JARDIANCE

Open Associated Drug #1: 0597-0152-30